TMDX

TransMedics Group Inc. Common Stock (TMDX)

Stock · NASDAQ · Health Care

$88.48as of 8/28/2026

Active signals

Support level
$67.61
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

How TransMedics Group Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$605.49MNet Income$190.29M (31%)Cost of Revenue$242.69M (40%)SG&A$185.17M (31%)R&D$69.06M (11%)TMDX

Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub

TransMedics Group Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • TMDX
    TransMedics Group Inc. Common Stock
    $88.48
    ▼ 3.57%
    Market cap $2.78BP/E
  • BLFS
    BioLife Solutions Inc. Common Stock
    $36.4
    ▼ 2.15%
    Market cap $1.66BP/E 29.72
    $17.86$38.1
  • CNMD
    CONMED Corporation Common Stock
    $49.98
    ▼ 0.68%
    Market cap $1.49BP/E 26.36
    $31.44$56.64
  • LIVN
    LivaNova PLC Ordinary Shares
    $80.34
    ▲ 0.39%
    Market cap $4.16BP/E 23.84
    $48.82$85.76
  • ELMD
    Electromed Inc. Common Stock
    $29.65
    ▼ 1.63%
    Market cap $348.09MP/E 34.86
    $23.01$47.4
  • CV
    CapsoVision Inc. Common Stock
    $5.95
    ▼ 1.82%
    Market cap $344.75MP/E
    $3.43$15.37
  • FOCL
    EDAP TMS S.A. American Depositary Shares
    $4.3
    ▼ 0.92%
    Market cap $228.65MP/E
    $4.01$6.4

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
34.58M
Total value held
$3.35B
Institutional holders
408
Top holders this quarter
  • Unknown5.29M
  • Unknown5.10M
  • Unknown1.48M
  • Unknown1.32M
  • Unknown1.04M
  • Unknown939.5K
  • Unknown885.8K
  • Unknown867.2K
  • Unknown866.3K
  • Unknown839.2K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.